Diagnostic Imaging Devices are used for the visualization of structural and functional patterns of organs or tissues. C-Arms use X-rays to generate real- time images of a patient’s body part. C-Arms are primarily used for the fluoroscopic imaging during surgical, orthopedic, critical care, traumatology, cardiology, and emergency care intraoperative interventions. GlobalData uses proprietary data and analytics to provide a comprehensive report on the c-arms devices market, including market shares of different players within Germany. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the c-arms market in Germany was Siemens Healthineers followed by Ziehm Imaging, GE Healthcare Technology, Philips Healthcare Informatics and Canon Medical Systems.
This includes Mobile C-Arms and Fixed C-Arms. Mobile C-Arms are devices with wheels attached to allow free movement throughout the facility. Fixed C-Arms are devices that are installed and cannot be moved from the room, most often installed from the ceiling.
The value of the c-arms devices market within Germany was expected to be over $200m in 2023.
For the latest complete market share analysis of c-arms device market in Germany, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
